8th World Cancer Congress - 2024

WHY YOU SHOULD ATTEND?

Network and Create Colloboration

Round Table Discussion

Global Town

Widely Discussion on Future Scope

Meet Top international scientists

Learn and discuss key industry news

HIGHLIGHTS OF THE CONFERENCE

Explore the implications of a changing health system on cancer prevention and control.
Impact of disparities on access and quality of cancer prevention and control.
Cancer prevention and focus on primary prevention.
Identify how to effectively address cancer survivorship across the continuum.
New innovations in Cancer research and technology.
Global cancer initiatives.
Better Clinical Practice.

INVITATION TO 8^TH WORLD CANCER CONGRESS - 2024

Arjyopa Healthcare and Ministry of AYUSH welcomes you to attend the 8th World Cancer Congress - 2024 during March 18^th - 20^th, 2024 at Jawaharlal Nehru Auditorium, AIIMS, New Delhi, India. We cordially invite all the participants interested in sharing their knowledge and research in the arena of Oncology and Cancer Research. From feedback received, the previous Congresses 2016, 2017, 2018, 2019, 2020, 2021, 2022 resulted in fruitful collaborations and rewarding experiences for the delegates who left the events with concrete tools and solutions that helped them enhance their work practice and impact. As hosts, we already feel very excited to create the same energetic and inspiring atmosphere during the Congress week, adding local flavors and new perspectives such as the role of complementary treatment in cancer to the programme.

The 8th World Cancer Congress - 2024 will also explore the new ideas and concepts on global scale and the topics on Cancer Biology & Genetics, Yoga and Naturopathy, Ayurveda and Cancer, Organ-Deﬁned Cancers, Oncology: Sub-Specialities, Radiation Oncology, Surgical Oncology, Cancer & Stem Cell Therapy, Precision Cancer Medicine & Oncology, Cancer Biomarkers, Cancer Epidemiology, Cancer Prevention & Research, Cancer Therapy & Treatments, Cancer Pharmacology, Cancer Vaccines, Cancer Immunology & Immunotherapy, Oncology Nursing and Care, Complementary & Alternative Methods and Cancer, Cancer Awareness and Survival, Cancer: Lifestyle and Nutrition, Cancer: Psychological & Social Aspects. The 8th World Cancer Congress – 2024 will also focus on Cancer Stem Cells, Cancer Basic & Applied Research Tumor, Anti Cancer Drug Discovery, Clinical Oncology and Personalized Cancer Medicine. It will give us novel insight into the complexity of the connections between Cancer and Metabolism &Immune Checkpoints, Cancer Biomarkers, Cancer Epidemiology, Cancer Prevention & Research, Cancer Therapy & Treatments, Cancer Pharmacology, Cancer Vaccines, Cancer Immunology & Immunotherapy, Oncology Nursing and Care, Complementary & Alternative Methods and Cancer, Cancer Awareness and Survival, Cancer: Lifestyle and Nutrition, Cancer: Psychological & Social Aspects, to deliver an outstanding program with the right balance of clinical relevance, which covers the entire spectrum of practice issues in Cancer Research and Treatments.

Thus, the urgent need to mobilize our efforts, promote cancer advocacy more efficiently and develop effective national policies and plans for prevention, early detection, care and support.

We look forward to the honor of welcoming you at New Delhi during the conference.

CHAIRMAN MESSAGE

On behalf of the Organizing Committee, it is my pleasure to invite all of the great scientists, academicians, young researchers, Business delegates and students from all over the world to attend the 8th World Cancer Congress – 2024 which has been scheduled from March 18^th – 20^th, 2024. The 8th World Cancer Congress – 2024 will be hosted at Jawaharlal Nehru Auditorium, AIIMS, New Delhi, India.

Cancer is the second leading cause of death worldwide. It’s crucial to remember that cancer is not one disease – it’s more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. Only worldwide research will enhance our understanding of cancer and help us find and develop better, more effective treatments. This year the world cancer congress - 2024 will also focused on swadashi treatment on cancer like AYURVEDA, Homeopathy Approach towards cancer treatment, Yoga and Naturopathy, UNANI medicine etc.

WCC2024 will be the best platform for all the Oncologists, Hematologists, Ayush Practioner, Cancer Researcher, Research scholars, Students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life.

We look forward to the honor of welcoming you at the summit.

With Warm Regards

Padma Shri Dr. Kodaganur S. Gopinath

Consultant Surgical Oncologist & Director

HCG, India

8^th World Cancer Congress - 2024 | New Delhi

KEYNOTE SPEAKERS/PRINCIPAL ADVISORY AND SCIENTIFIC COMMITTEE

Padma Shri Dr. Anil D'Cruz

Director, Oncology,

Apollo Hospital, INDIA

Padma Shri Dr. Lalit Kumar

Prof & HOD, Dept of Medical Oncology,

AIIMS, INDIA

Padma Shri Dr. Ashok Gupta

Senior Plastic Surgeon,

BHIMS, INDIA

Dr. G. K. Rath

Chief-Radiation Oncologist,

AIIMS, INDIA

Padma Shri Dr. Ramakant K. Deshpande

Senior Oncologist & Director,

Asian Cancer Institute, INDIA

Padma Shri Dr. Kamini Rao

Senior Gynaec-Oncologist,

MILANN, INDIA

Dr. Raghavendra Rao

Director-CCRYN,

Ministry of AYUSH, INDIA

Dr. Shyam Aggarwal

Senior Medical Oncologist,

Sir Ganga Ram Hospital, INDIA

Dr. Ashok Sharma

Additional Professor,

AIIMS/NCI-Jhajjar, INDIA

Dr. Birandra K Sinha

Senior Scientist,

NIH, USA

Prof. Debu Tripathi

Dept. of Breast Medical Oncology

MD Anderson Cancer Center, USA,

Dr. Mukund S. Didolkar

Dept. of Surgical Oncology,

Sinai Hospital, Baltimore,USA

Dr. Shreyash Kumar Patel

Dept. of Sarcoma Medical Oncology,

MD Anderson Cancer Center, USA

Dr. Arun Kumar

Dept. of Pharmacology and Toxicology,

University College Dublin, Ireland

Prof. Ashutosh Tewari

Dept. of Urology,

Icahn School of Medicine, Mount Sinai, USA

Dr. Mukesh Verma

Epidemiology and Genomics Research Program,

NIH, USA

Prof. Anuraag Shrivastava

Dept of Biology,

University of Winnipeg, Canada

Prof. Raghu Sinha

Dept of Biochemistry and Molecular Biology,

Penn State Cancer Institute, USA

SCIENTIFIC SESSION

Track 1: Bladder Cancer
Track 2: Bone Cancer
Track 3: Brain Cancer
Track 4: Breast Cancer
Track 5: Cancer Genetics & Genomics
Track 6: Cancer Immunotherapy & Vaccines
Track 7: Cancer Metabolism
Track 8: Cell Signalling & Regulation
Track 9: Cell-Based Therapy
Track 10: Chemical Biology
Track 11: Chronic Myeloid Leukemia
Track 12: Chronic Lymphocytic Leukemia
Track 13: Developmental Biology
Track 14: Endocrine Cancer
Track 15: Epidemiology
Track 16: Epigenetics
Track 17: Exercises Oncology
Track 18: Imaging
Track 19: Immunology
Track 20: Lung Cancer
Track 21: Lymphoma
Track 22: Palliative Care
Track 23: Genome Integrity
Track 24: Gynecologic Cancer

Track 25: Microbiome & Inflammation
Track 26: Molecular Pathology & Diagnostics
Track 27: Multiple Myeloma
Track 28: Nanotechnology
Track 29: Neuroscience & Neuro-Oncology
Track 30: Renal Cell Carcinoma
Track 31: Sarcoma
Track 32: Skin Cancer
Track 33: Side Effect Management
Track 34: Solid Tumor Oncogenesis
Track 35: Stem Cells
Track 36: Structural Biology
Track 37: Systems Biology
Track 38: Targeted Therapy
Track 39: Tumor Micro Environment
Track 40: Urologic Cancers
Track 41: Pancreatic Cancer
Track 42: Pediatric Cancer
Track 43: Prostate Cancer
Track 44: Gastrointestinal Cancer
Track 45: Head & Neck Cancer
Track 46: Hematologic Malignancies
Track 47: HPV & Cervical Cancer
Track 48: Metastasis & Drug Resistance

SUBMIT ABSTRACT

Authors are invited to submit abstract(s) using the submission form on this page. Abstracts should contain sufficient detail on the techniques used and the results, which will be shown. You will receive a confirmation when the abstract has been received. Please contact the conference secretariat if you did not receive confirmation within 5 working days. Submission implies the intent of at least one author to register, attend the symposium and present the paper orally or in poster format. Contributions will only be finally accepted after registration and payment of the conference fee. The abstract will be reviewed, and you will be notified of acceptance.

The entire body of the abstract, excluding tables, must not exceed 250 words. Spaces are not included in this number. Title, authors’ names, affiliations, figures, and tables are not included in the character count.
The abstract may be structured (i.e., abstracts divided into sections using terms such as Introduction, Methods, Results, Conclusions, etc.) or unstructured.
Do not use bold type or underline formatting. Italic type is acceptable.
Text may be in multiple paragraphs.
Any references should be noted as citations within the text and not as footnotes at the end

Important Dates

1^st Abstract Submission Deadline: 17^th November, 2023

Early Bird Registration Closes: 27^th February, 2023

Click Here to Submit Abstract

Click Here to Download Brochure

PAST SPONSORS